LOCAL NEWS, DELIVERED DAILY. Subscribe to our daily news wrap and get the top stories sent straight to your inbox every evening.
By Canadian Press

Shortage of diabetes and weight loss drug Ozempic expected in Canada: manufacturer

Aug 18, 2023 | 9:29 AM

A shortage of diabetes drug Ozempic that is used off-label for weight loss is expected in Canada, the manufacturer says. 

Novo Nordisk says it is experiencing a temporary supply disruption with the Ozempic 1 mg injection pen. 

It says the shortage is due to a combination of global supply constraints and increased demand for the drug.

Health Canada says intermittent shortages are expected from late August to early October.

Both Health Canada and Novo Nordisk say the 0.25 mg and 0.5 mg doses of Ozempic remain available for patients with Type 2 diabetes.  

cub rescue
Two orphaned Island bear cubs rescued after mom found dead
12h ago
ready, set, go!
VIDEO: Local kids test gravity with homemade cars
11h ago
lunar look
Artemis on track to break record set by Apollo 13 during lunar flyby
15h ago

They say pharmacists are encouraged to limit refill prescriptions to a 30-day supply.  

This report by The Canadian Press was first published Aug. 18, 2023.

Canadian Press health coverage receives support through a partnership with the Canadian Medical Association. CP is solely responsible for this content

Nicole Ireland, The Canadian Press

by Canadian Press

More Local News

cub rescue
Two orphaned Island bear cubs rescued after mom found dead
12h ago
ready, set, go!
VIDEO: Local kids test gravity with homemade cars
11h ago
lunar look
Artemis on track to break record set by Apollo 13 during lunar flyby
15h ago
fair trade practices
Global Village Nanaimo spring store ready to open
18h ago
New Heights
Olivia Lundman to compete in marathon distance at World Race Walking Championships
Apr 05, 2026